Latest news
Loading news…
DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.
DTx Pharma was acquired by Novartis in 2023 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
21
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Diego, California, United States
Key People at DTx Pharma
Chief Business Officer
COO
Chief Medical Officer
21
professional contacts at DTx Pharma
Contact execs at DTx Pharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to DTx Pharma
Loading news…
FAQs about DTx Pharma
People who checked this page also checked these
Browse the full Acquirezy directory.